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Abstract
Background: The exocrine pancreas is composed of a branched network of ducts connected to acini.
They are lined by a monolayered epithelium that derives from the endoderm and is surrounded by
mesoderm-derived mesenchyme. The morphogenic mechanisms by which the ductal network is
established as well as the signaling pathways involved in this process are poorly understood.
Results: By morphological analyzis of wild-type and mutant mouse embryos and using cultured embryonic
explants we investigated how epithelial morphogenesis takes place and is regulated by chemokine signaling.
Pancreas ontogenesis displayed a sequence of two opposite epithelial transitions. During the first
transition, the monolayered and polarized endodermal cells give rise to tissue buds composed of a mass
of non polarized epithelial cells. During the second transition the buds reorganize into branched and
polarized epithelial monolayers that further differentiate into tubulo-acinar glands. We found that the
second epithelial transition is controlled by the chemokine Stromal cell-Derived Factor (SDF)-1. The latter
is expressed by the mesenchyme, whereas its receptor CXCR4 is expressed by the epithelium.
Reorganization of cultured pancreatic buds into monolayered epithelia was blocked in the presence of
AMD3100, a SDF-1 antagonist. Analyzis of sdf1 and cxcr4 knockout embryos at the stage of the second
epithelial transition revealed transient defective morphogenesis of the ventral and dorsal pancreas.
Reorganization of a globular mass of epithelial cells in polarized monolayers is also observed during
submandibular glands development. We found that SDF-1 and CXCR4 are expressed in this organ and
that AMD3100 treatment of submandibular gland explants blocks its branching morphogenesis.
Conclusion: In conclusion, our data show that the primitive pancreatic ductal network, which is lined by
a monolayered and polarized epithelium, forms by remodeling of a globular mass of non polarized epithelial
cells. Our data also suggest that SDF-1 controls the branching morphogenesis of several exocrine tissues.
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Background
Branching morphogenesis is a process that allows the for-
mation of a branched network of tubes, as exemplified by
the airways of the lung or the excretory ducts of the pan-
creas and salivary glands [1,2]. During branching mor-
phogenesis, the epithelial cells interact with the
surrounding mesenchyme and organize into polarized
monolayers with their apical pole facing the tube lumen
[3,4]. How this process takes place and is regulated in exo-
crine tissues such as the pancreas and salivary glands
remains poorly understood.
In the mouse, the pancreas originates from a pre-pat-
terned endodermal epithelium located in a caudal region
of the foregut that is to become the duodenum. Between
embryonic days (e) 8.5 and e9.5, two outgrowths develop
from the dorsal and ventral sides of this endodermal
region, and form epithelial buds surrounded by mesen-
chyme. From e9.5-e10.5 onwards, the pancreatic bud cells
proliferate, differentiate and undergo extensive morpho-
genesis to generate ductal structures called primitive
ducts. The latter then expand, and give rise to the endo-
crine islets of Langerhans and to a branched ductal net-
work that drains the secretions of the exocrine acini [5-
10]. The submandibular glands (SMG) also derive from
the foregut endoderm. Their development starts around
e11.5 by formation of two epithelial thickenings beneath
the tongue. These thickenings protrude into the underly-
ing mesenchyme. Around e13.5, small clefts appear at the
periphery of the budding epithelial mass, and after con-
tinuous proliferation and repetitive clefting, a tree-like
network of ducts whose branches end in acini is generated
[11,12].
Regulation of epithelial morphogenesis in the pancreas
and SMG is controlled by the surrounding mesenchyme
[13,14]. Moreover, gene inactivation studies and ex vivo
culture experiments have identified several signaling mol-
ecules that regulate SMG branching morphogenesis [15-
19]. In the developing pancreas, gene inactivation studies
inhibiting FGF10, EGF, or Rbpj expression revealed
impaired branching morphogenesis. However, these stud-
ies focused on the role of the signaling molecules on pan-
creatic cell differentiation and not on the mechanisms of
branching [20-23].
Stromal cell-Derived Factor-1 (SDF-1, also called CXCL12
or PBSF) is a secreted protein of the α-chemokine family,
and a potent chemoattractant for many cell types [24-26].
Whereas SDF-1 is the sole ligand for the chemokine CXC-
motif receptor 4 (CXCR4), CXCR7 can bind SDF-1 and
CXCL11/I-TAC [27]. Sdf1 and cxcr4 knockout mice die
perinatally and display profound defects in the hemat-
opoietic and nervous system [28-32], whereas cxcr7
knockout embryos die at birth due to defects in heart for-
mation [33]. No role has been ascribed to SDF-1/CXCR4
signaling in the SMG. In contrast, two functions for SDF-
1 signaling in adult pancreas have been proposed. One
day before birth, when pancreatic cells still differentiate
and extensive islet neogenesis occurs, CXCR4 is expressed
in endocrine cells and in some ductal cells, whereas SDF-
1 is only found in endocrine cells [34]. The same expres-
sion pattern persists in adult pancreas. Using a genetic
model of endocrine pancreas regeneration (mice express-
ing IFN-γ under the control of the insulin gene promoter),
it was proposed that SDF-1 is involved in endocrine cell
renewal [34]. More recently, it has been shown that SDF-
1 promotes β-cell survival, via activation of Akt, in adult
mouse islets [35]. However, it is not known if SDF-1/
CXCR4 signaling plays a role in early pancreas develop-
ment.
In this paper we show that pancreatic epithelial morpho-
genesis occurs according to a sequence of two opposite
epithelial transitions. During the first transition the mon-
olayer of endodermal cells lining the primitive gut gives
rise to two pancreatic buds, each composed of a mass of
non polarized epithelial cells. During the second transi-
tion, this mass reorganizes into branched polarized epi-
thelial monolayers that further differentiate into ducts
and acini. Similar sequential transitions were described
earlier in the SMG [12,14]. In the pancreas and SMG, sdf1
was expressed by the mesenchyme and cxcr4 by the epi-
thelial cells. Using embryonic explants of pancreas and
SMG, and mice deficient in SDF-1 signaling, we uncov-
ered a new role for SDF-1 in branching morphogenesis.
Results
Primitive duct morphogenesis and cell polarization during 
pancreas development
To obtain a better insight into the regulation of branching
morphogenesis in developing pancreas, we first analyzed
primitive duct morphogenesis and epithelial cell polariza-
tion. We visualized epithelial cells (E-cadherin), their api-
cal pole lining the lumen (mucin-1), and the basal lamina
(laminin) separating the epithelial cells from the mesen-
chyme on sections from e10.5 to e15.5 pancreas (Figure
1). At e10.5 and e11.5, the pancreatic buds had a globular
shape, and most epithelial cells were not polarized, as
they were not lined by laminin (basal marker) and did not
show mucin-1 (apical marker). At e12.5, the shape of the
pancreas became irregular. Lumina of primitive ducts, still
surrounded by several layers of epithelial cells became
detectable from e13.5 onwards. The pancreas then pro-
gressively gave rise to the primitive ductal network, com-
posed of a polarized and monolayered epithelium
surrounded by mesenchyme. At e15.5, all epithelial cells
were polarized and showed apical, lateral and basal
domains (Figure 1). Very few apoptotic cells were detected
during these stages, and they were exclusively localized inBMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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Remodeling of the pancreatic epithelial cell mass into polarized monolayers Figure 1
Remodeling of the pancreatic epithelial cell mass into polarized monolayers. Pancreatic sections from e10.5 to 
e15.5 embryos were examined by immunofluorescence using antibodies directed against E-cadherin, mucin-1 and laminin. Pan-
creatic development starts by the formation of a mass of non-polarized epithelial cells (e10.5-e11.5). This mass is then remod-
eled (e12.5-e13.5) and finally every epithelial cell become polarized, with its basal pole contacting laminin and its apical pole 
facing a lumen (e14.5-e15.5). * indicates the central duct, in connection with the duodenum. Scale bar, 100 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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the non-epithelial compartment (Additional file 1). We
concluded that the formation of the primitive pancreatic
ductal network occurs by remodeling of a globular mass
of epithelial cells, rather than from iterative branching of
a monolayer.
We then further characterized the morphology and the
cells of the e11.5 pancreatic bud. In addition to the central
duct lumen (asterisk in Figure 1, 2A, and Additional file
1), intense mucin-1 stainings also appeared as dots at the
periphery of the pancreatic buds (Figure 2A). These stain-
ings corresponded to small developing lumina, called
here secondary lumina. Three-dimensional confocal
reconstructions were generated to determine the spatial
relationship between these secondary lumina and the cen-
tral duct lumen. No connection between the central and
the peripheral lumina were detected, indicating that the
latter are blind and independent from the central lumen
(Figure 2B; white arrowhead, b to g; red arrowhead, f to k;
Additional file 2). Furthermore, a section through the
e11.5 pancreatic bud stained for E-cadherin and mucin-1
expression showed that the cells of the outer layer are
morphologically different from internal cells (Figure 2C).
The outer cells had a cylindrical shape and a basal
nucleus. Their apical pole faced the peripheral lumina, as
shown by mucin-1 staining (arrows in Figure 2C). In addi-
tion, the localization of two intracellular markers in this
outer epithelial layer was typical of polarized cells (Figure
2D). The Golgi marker GM-130 was found on the apical
side of the nucleus, and the microtubule-organizing
center (MTOC) detected by pericentrin staining was
located in the subapical region of the cells. In contrast,
except for the cells that lined the central duct lumen, the
internal cells of the pancreatic bud showed no mucin-1
expression and the localization of the Golgi and MTOC
was random. Altogether, these data indicated that the
pancreatic bud is a compact epithelial mass, in which the
cells are not polarized, except for the outer cells which all
have basal and lateral membrane domains; some cells
also posses an apical domain.
To characterize the acquisition of cell polarity during the
transition of a globular pancreatic bud to the monolay-
ered epithelium lining the primitive ducts, we analyzed
the formation of tight junctions. The latter play a role in
cell adhesion and in the establishment and maintenance
of apico-basal polarity [36]. To this end, we studied the
localization of the tight junction-specific protein ZO-1
from e10.5 to e15.5 (Figure 3A). Despite the continuous
presence of adherens junctions (E-cadherin) between
pancreatic epithelial cells, strong ZO-1 staining was not
detected in the pancreas before e12.5. From that stage on,
ZO-1 was progressively seen in cells facing a lumen (Fig-
ure 3A). Therefore, ZO-1 localization at the tight junctions
was subsequent to the onset of polarization of peripheral
cells in the e11.5 pancreatic bud and was concomitant
with the remodeling of the epithelial bud into a monolay-
ered epithelium lining the primitive duct lumina.
A similar epithelial transition, from a mass to monolayers,
also occurs during submandibular gland (SMG) morpho-
genesis [12,13]. As shown in Figure 3B, ZO-1 staining was
not visible in the early stage of SMG morphogenesis and
only became visible after remodeling of the epithelial
mass into monolayers lining a lumen (Figure 3B). High
magnification pictures of epithelial cell monolayers
clearly demonstrated that ZO-1 separates the apical
domain (now devoid of E-cadherin staining) from the lat-
eral domain (insets in Figure 3A and 3B).
SDF-1 and its receptor CXCR4 are expressed in developing 
pancreas and SMG
The mesenchyme is a source of morphogenesis-inducing
signals in the pancreas [37] and in the SMG [17]. There-
fore, we looked for mesenchymal factors that could regu-
late epithelial morphogenesis in these organs and
considered SDF-1 as a candidate. Indeed, this chemokine
and its G protein-coupled receptor CXCR4 have been pro-
posed to control cell movement in many developing
organs [38], including the endoderm during zebrafish gas-
trulation [39]. At the late stages of pancreas development,
this signaling pathway is involved in pancreatic cell
migration and β-cell survival [34,35]. We first investigated
the expression pattern of SDF-1 and CXCR4 in the pan-
creas by performing in situ hybridization experiments. We
focused on embryos at e12.5, when epithelial cells are
organized in a globular mass, and e14.5, when remode-
ling has been initiated. We found that sdf1  is mainly
expressed in the mesenchyme, with lower staining inten-
sity in the epithelium; cxcr4 was found in epithelial cells,
as early as e12.5 (Figure 4A and 4B). Sdf1 and cxcr4 expres-
sion was also found in the vasculature (arrows in Figure
4A and 4B). This expression pattern was maintained up to
e14.5, a stage at which sdf1 expression in the central most
region of the epithelium became intense (Figure 4C and
4D).
In the developing SMG, the expression of Sdf1 and Cxcr4
was comparable to that in the pancreas (Figure 4E to 4H).
From e12.5 to e14.5: sdf1 was expressed in the mesen-
chyme and cxcr4 in the epithelium. Moreover, CXCR7, the
second receptor for SDF-1, was observed by immunolo-
calization in endothelial structures of the SMG (Addi-
tional file 3), but not of the pancreas (not shown). From
this set of expression data, we concluded that the spatial
and temporal expression pattern of SDF-1 and CXCR4 in
the pancreas and SMG suggests a potential role for SDF-1
signaling in their development.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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The pancreatic buds consist of an epithelial cell mass with peripheral lumina Figure 2
The pancreatic buds consist of an epithelial cell mass with peripheral lumina. (A) Whole mount immunoanalyzis of 
dorsal and ventral pancreatic buds at e11.5 with an anti-mucin-1 antibody. The staining delineates the apical pole of cells lining 
the lumen of the primitive gut tube, the pancreatic central duct (*) and its extensions. It also shows blind lumina at the periph-
ery of the pancreatic bud. (B) Gallery of pictures from a 3D confocal acquisition on a whole-mount immunofluorescence ana-
lyzis of e11.5 dorsal pancreas with anti Mucin-1 (green) antibody. Blind peripheral lumina can be observed from b to g (white 
arrowheads) and from f to k (red arrowheads). (C, D) Sections of e11.5 dorsal pancreatic bud stained with antibodies against 
E-cadherin and mucin-1 (C) and pericentrin and GM-130 (D). Nuclei are labeled with TOPRO. Epithelial cells at the periphery 
of the pancreatic bud (E-cadherin, dashed line) show polarized staining of mucin-1 (arrows), pericentrin and GM-130. * indi-
cates the central duct. Scale bars, 50 μm (A); 20 μm (B); 10 μm (C, D).BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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Primitive duct morphogenesis occurs by transition from epithelial mass to monolayers in the pancreas and in the SMG Figure 3
Primitive duct morphogenesis occurs by transition from epithelial mass to monolayers in the pancreas and in 
the SMG. Pancreatic sections from e10.5 to e15.5 (A) and SMG sections from e13.5 to e16.5 (B) embryos were examined by 
immunofluorescence using antibodies directed against ZO-1 and E-cadherin. Both organs show that duct development occurs 
by remodeling of a mass of epithelial cells into polarized monolayers. Before remodeling, E-cadherin is expressed all around the 
cells, whereas it is restricted to the baso-lateral membranes in the monolayered epithelium. In the latter, ZO-1 (tight junction) 
separates the E-cadherin-negative apical pole from the E-cadherin-positive lateral domains (insets). * indicates the central duct, 
in connection with the duodenum (A). Scale bars, 50 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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SDF-1 signaling controls pancreatic branching 
morphogenesis
To address the role of SDF-1 signaling in epithelial mor-
phogenesis, we resorted to explants of e12.5 pancreas cul-
tured on filters. Pancreatic cultures have only been
validated for analyzing pancreatic cell differentiation
when investigating the role of extracellular factors [40].
Therefore, we first validated the pancreatic explants as a
model for studying branching epithelial morphogenesis.
At the start of the culture (Day 0 in Figure 5A) the explants
presented as an epithelial cell mass surrounded by mesen-
chyme, showing early signs of branching and small, inde-
pendent, lumina. After 5 to 7 days of culture, the
epithelial mass was remodeled into tubulo-acinar epithe-
lial monolayers imbricated within the mesenchyme, as
described  in vivo (Figure 1). Most epithelial cells had
acquired polarity with the apical pole facing a well-
defined lumen, as revealed by mucin-1 staining, and the
basal pole facing the mesenchyme (Day 7 in Figure 5A).
We concluded that cultured pancreatic explants provide a
model to analyze the formation of the primitive ductal
network.
To investigate if SDF-1 controls epithelial morphogenesis
in developing pancreas, we performed gain- and loss-of-
function experiments by treating cultured explants with
exogenous recombinant SDF-1 and with a specific phar-
macological inhibitor of CXCR4 (AMD3100) [41]. Pan-
creatic explants cultured for 7 days were analyzed by
immunofluorescence with antibodies against E-cadherin
and mucin-1. No effect of exogenous SDF-1 on epithelial
organization was observed as compared to control
explants (Figure 5B). The absence of effect of exogenous
SDF-1 is likely to result from the presence of endogenous
SDF-1, whose activity cannot be amplified. In contrast, we
found that upon AMD3100 treatment, morphogenesis
was impaired (Figure 5B). Epithelial monolayers were not
formed and the epithelial cells remained clustered. The
SDF-1 and its receptor CXCR4 are expressed in developing mouse pancreas and SMG Figure 4
SDF-1 and its receptor CXCR4 are expressed in developing mouse pancreas and SMG. Pancreatic (A-D) and SMG 
(E-H) sections at e12.5 (A, B, E and F) and e14.5 (C, D, G and H) were processed for in situ hybridizations using antisense 
probes for SDF-1 and for CXCR4. SDF-1 is expressed in the mesenchyme and its receptor in epithelial cells (pancreatic epithe-
lium is delineated by a dotted line). At e14.5, SDF-1 staining is also found in pancreatic epithelial cells. Capillaries are positive 
for both the ligand and receptor (arrows). Scale bars, 100 μm (A-D); 200 μm (E-H).BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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Figure 5BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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mesenchyme was not imbricated with the epithelium and
remained at the periphery of the explants. The lumina, as
revealed by mucin-1 staining, were smaller and often sur-
rounded by multiple layers of epithelial cells. Identical
results were obtained with explants from e11.5 embryos
(data not shown), and the effect of AMD3100 was dose-
dependent, since milder anomalies were observed at 10
μM than at 20 μM. Thus, at the end of the culture, the
AMD3100-treated explants resembled the e12.5 pancreas
before the onset of remodeling into a monolayered epi-
thelium (compare AMD3100 panels of Figure 5B with
Day 0 panels of Figure 5A). AMD3100 treatment did not
change the proliferation or the apoptosis index (Addi-
tional file 4A, B) and this was supported by the normal
size of these explants. Immunostaining with antibodies
against insulin, glucagon or carboxypeptidase-A revealed
normal differentiation in the explants treated with
AMD3100 (Additional file 4C). From these experiments
we concluded that SDF-1/CXCR4 signaling is potentially
required for the remodeling of the epithelial cell mass into
primitive pancreatic ducts lined by a monolayered epithe-
lium.
SDF-1 signaling controls SMG branching morphogenesis
To investigate if SDF-1 modulates branching morphogen-
esis of other exocrine glands, we addressed the role of
SDF-1 signaling in SMG epithelial morphogenesis. As
shown above, this organ develops according to the same
two-stage epithelial transition as in the pancreas
[12,14,42]. We resorted to cultures of e13.5 embryonic
explants, as described earlier by others [14-19]. The SMG
epithelial bud surrounded by its mesenchyme was excised
and cultured on filter for up to 3 days in the presence of
SDF-1 and SDF-1 antagonists. Similarly to the pancreas,
gain-of-function experiments with exogenous SDF-1 did
not affect SMG branching (Figure 6A). However, upon
AMD3100 treatment, morphogenesis of the SMG was
impaired (Figure 6A). The size of the glands was smaller
and the number of epithelial buds was reduced, as com-
pared to control glands, indicating that SDF-1 signaling is
required for branching. Quantification of the number of
buds in AMD3100-treated explants revealed a reduction
in the budding index (number of buds at day 1, 2 or 3
divided by the number of buds at day 0), as early as one
day after the onset of the treatment, and culminating at
80% reduction after 3 days, as compared to control cul-
tures (Figure 6B). As CXCR7 was also expressed in the
blood vessels surrounding the SMG (Additional file 3),
the SDF-1 antagonist CCX733, which prevents SDF-1
from binding to CXCR7, was also tested. As shown in Fig-
ure 6A, CCX733 inhibited SMG morphogenesis by reduc-
ing the number of epithelial buds. This was confirmed by
a 60% reduction in the budding index as compared to
controls after 3 days (Figure 6B). These experiments sug-
gested a role for SDF-1 signaling via CXCR4 and CXCR7
in the branching morphogenesis of the SMG.
We further investigated the morphogenic defect observed
by the addition of AMD3100 to the culture. As SDF-1 sig-
naling can control both cell survival and cell proliferation
in different cell types, blocking SDF-1 binding to CXCR4
with AMD3100 could explain the reduced size of the
glands. Therefore, we performed immunodetection of
phosphohistone H3, a marker of mitosis, and of activated
caspase 3, a marker of cell apoptosis, in control,
AMD3100- and CCX733-treated explants. Quantification
of these stainings revealed that proliferation was not
affected when SDF-1 signaling was abrogated (Figure 7A).
However, apoptosis showed a three-fold increase in the
epithelial buds of AMD3100-treated explants (Figure 7A).
This observation could explain the reduced size of the
SMG epithelium. We then assessed whether the increase
in apoptosis was the cause of the branching defect. For
this, we cultured explants in the presence of AMD3100
alone or in combination with a general inhibitor of cas-
pases. Apoptosis was effectively prevented as revealed by
the near complete absence of activated caspase 3 staining
on sections from caspase inhibitor-treated explants (Addi-
tional file 5). However, in the explants co-cultured with
AMD3100 and the caspases inhibitor, the branching
defect was still observed (Figure 7B), indicating that the
reduced branching activity is not a consequence of
increased apoptosis. Since SDF-1 did not affect cell sur-
vival in developing pancreas (see above) but did control
branching morphogenesis of the pancreas, we conclude
SDF-1 signaling controls pancreatic branching morphogenesis Figure 5
SDF-1 signaling controls pancreatic branching morphogenesis. Immunofluorescence analyzis of pancreatic tissue 
stained for E-cadherin, mucin-1 and DNA. (A) The dorsal pancreatic bud was dissected from e12.5 embryos and either fixed 
and processed for immunostainings (= e12.5 = day 0) or cultured on filter for 7 days (= day 7) prior to immunostaining analyzis. 
Dissected mouse e12.5 pancreas before the culture (Day 0) appears as a mass of epithelial cells (red; E-cadherin-positive) sur-
rounded by mesenchyme (E-cadherin-negative). Some cells accumulate mucin-1 at their apical pole, but no lumina are formed. 
After 7 days in culture (Day 7), the epithelial mass has been remodeled and cells are polarized and form monolayers delineating 
lumina. (B) e12.5 pancreatic explants dissected from wild-type mouse and cultured for 7 days. Control and SDF-1 (300 ng/ml) 
treated explants form polarized monolayers delineating lumina and imbricated with mesenchyme. In contrast, treatment of the 
pancreatic explants with 20 μM AMD3100, a specific pharmacological inhibitor of CXCR4, inhibits epithelial morphogenesis, as 
seen by the maintenance of the epithelial cells in clusters. Scale bars, 50 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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that SDF-1 has differential effects on organ development,
but that it has common effects on epithelial branching.
Genetic deficiency of CXCR4 or SDF-1 transiently affects 
epithelial morphogenesis
To verify in vivo the relevance of our ex vivo observations,
we analyzed the morphogenesis of embryonic pancreas in
sdf1 knockout mice. At e12.5 the ventral pancreas in sdf1
knockouts showed less branching and had a more globu-
lar shape as compared to controls, confirming the role of
SDF-1 in branching morphogenesis (Figure 8A). The
degree of branching was evaluated by counting the
number of buds and clefts in control and knockout ven-
tral pancreas. This quantification revealed a two-fold
decrease in the number of buds in the absence of SDF-1
(Figure 8B). However, the dorsal pancreas did not show
obvious branching defects, but was more elongated than
in controls and it adopted a hammerhead-like structure
while the controls were more rounded. The branching
defect was transient since e13.5-e14.5sdf1-/- embryos did
not show deficient morphogenesis (data not shown).
Since the consequences of Sdf1 ablation in vivo were rather
modest as compared to the effects of Sdf1 inhibition in
vitro, we looked at cxcr4-/- pancreas. At e12.5 and e15.5,
the dorsal and ventral pancreata were not significantly dif-
ferent in cxcr4-/- embryos and in wild-type animals (not
shown). However, when cultured on filters cxcr4-/- pancre-
atic explants showed a strong morphogenic deficiency,
similar to that seen when wild-type explants were cultured
in the presence of AMD3100, a SDF-1 antagonist (com-
pare Figure 8B with Figure 5B). This similarity proves that
AMD3100 specifically targets and inhibits SDF-1 signal-
ing via the CXCR4 receptor. Taken together, these data
indicated that SDF-1 controls pancreas morphogenesis in
vivo, but also suggest that compensatory effects operating
SDF-1 signaling controls SMG branching morphogenesis Figure 6
SDF-1 signaling controls SMG branching morphogenesis. (A) Representative whole-mount immunostaining of E-cad-
herin in explants cultured for three days with the control medium, SDF-1, AMD3100 or CCX733. Control and SDF-1-treated 
cultures show that the epithelium has invaded the whole culture and forms a complex arborescence. In contrast, treatment of 
the SMG explants with 20 μM AMD3100 inhibits epithelial branching morphogenesis, as seen by the failure to colonize the 
explant mesenchyme and the reduced number of buds. Similarly, CCX733 reduces the branching as well as the invasion of the 
mesenchyme. (B) The numbers of terminal buds in each cultured SMG explants were counted at day 0, 1, 2 and 3, and the bud-
ding index was calculated by dividing the number of buds at day 1, 2 and 3 by the number of buds at day 0. t-test: *, P < 0.001. 
Scale bar, 500 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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SDF-1 signaling promotes epithelial cell survival in the SMG Figure 7
SDF-1 signaling promotes epithelial cell survival in the SMG. (A) Quantification of the number of epithelial cells posi-
tive for the cleaved caspase 3 (left panel), or phosphohistone H3 (right panel) in SMG explants cultured for 24 hours. All the 
epithelial cells positive for the marker were counted on every sixth sections of the explant and total number was normalised to 
its size. Values for control explants were set as 100. t-test: *, P < 0.05. (B) Representative whole-mount immunostaining of E-
cadherin in explants cultured for two days in the presence or absence of a general caspase inhibitor. Blocking caspase activity 
does not affect branching activity in control or AMD3100-treated explants. Scale bars, 500 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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SDF-1 signaling controls pancreatic branching morphogenesis in vivo Figure 8
SDF-1 signaling controls pancreatic branching morphogenesis in vivo. (A) Representative immunostainings of two 
e12.5 control and sdf1 knockout pancreata with E-cadherin and mucin-1 antibodies. Reduced branching activity is observed in 
sdf1-/- ventral and dorsal pancreas (B) Quantification of the degree of branching in four e12.5 control and four sdf1 knockout 
pancreata. The organs were sectioned and the number of buds and clefts were counted on every sixth sections and the average 
numbers per ventral pancreata sections are given. (P < 0.0005) (C) Pancreatic explants were dissected at e12.5 from wild-type 
or cxcr4-/- mouse embryos and cultured for 7 days. CXCR4-deficient explants do not remodel into polarized epithelial monol-
ayers and exhibit the same morphogenetic defects as wild-type explants treated with AMD3100. Scale bar, 50 μm.BMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
Page 13 of 17
(page number not for citation purposes)
in vivo mask part of the role of SDF-1. We also analyzed
the development of SMG in cxcr4-/- and sdf1-/- embryos,
but the SMG phenotypes appeared normal, both in vitro
and in vivo. We concluded that no genetic evidence for a
role of SDF-1 signaling in SMG branching could be col-
lected. However, the existence of compensatory mecha-
nisms for genetic deficiencies in the pancreas suggests that
compensation may also occur in the SMG.
Discussion
In this paper we show that the primitive pancreatic ductal
network, which is lined by a monolayered and polarized
epithelium, forms by remodeling of a globular mass of
non polarized epithelial cells. SDF-1 is expressed in the
mesenchyme surrounding the epithelium and its receptor
CXCR4 is found in the epithelial cells of the pancreas.
SDF-1 signaling promotes branching morphogenesis of
the pancreas in vitro and in vivo. We also provide in vitro
evidence that SMG morphogenesis is controlled by SDF-1.
Previous models depicting pancreatic duct morphogene-
sis in mammals suggest that it results from the branching
of a polarized epithelium [7,43]. We show here that for-
mation of the primitive ductal network is not initiated by
iterative branching of a tubular structure extending from
the gut (Figure 9). The pancreatic bud at e10.5-e11.5 con-
sists of a globular mass of epithelial cells with a central
duct lumen. This lumen, connected to the gut tube lumen,
forms extensions within the pancreatic bud, and is sur-
rounded by several layers of cells. These cells are linked by
Development and banching morphogenesis of the pancreas Figure 9
Development and banching morphogenesis of the pancreas. Pancreatic specification of polarized endodermal cells 
leads to the formation of a multilayered and then globular mass of epithelial cells with a central duct lumen (pancreatic bud). 
This lumen, connected to the gut tube lumen, forms extensions within the pancreatic bud, and is surrounded by several layers 
of cells, linked by adherens junctions (E-cadherin), but lacking tight junctions (ZO-1). Around e11.5, before remodeling of the 
mass, some cells at the periphery acquire apico-basal polarity and delineate blind lumina (secondary lumina). Initial branching 
morphogenesis events result from the coalescence of secondary and central lumina, allowing the progression towards epithe-
lial monolayers.
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adherens junctions (E-cadherin), but lack tight junctions
(ZO-1). At this stage, we observe that some cells at the
periphery of the mass show apico-basal polarity and
delineate blind lumina (secondary lumina). Based on
these observations, we propose that primitive duct
branches arise from extensions of the central gut-derived
duct that fuse with secondary lumina that appear at e11.5.
Interestingly, this process bears resemblance with lumen
development in the zebrafish gut tube and exocrine pan-
creas. Indeed, in these organs the lumen arises by fusion
of multiple lumina [44,45]. After the formation of primi-
tive ducts, further branching and expansion of the pancre-
atic ducts occur by iterative lateral branching, as
illustrated by Puri and Hebrok [46]. This is also similar to
the development of the mouse SMG, where the epithelial
cells first form a mass that becomes remodeled into a
monolayered epithelium. Like in the pancreas, epithelial
cells in the SMG express E-cadherin and β-catenin. ZO-1
is only detectable when cells are lining a lumen
[11,12,42].
The time-course and 3-D analysis of embryonic pancreas
development indicated that an initial phase of polariza-
tion occurs in cells of the outermost layer of the pancreatic
bud at e11.5. This precedes remodeling of the bud, sug-
gesting that, at the onset of pancreas development,
remodeling may be triggered by the acquisition of polarity
and not the reverse. Beyond this stage, acquisition of
apico-basal polarity and primitive duct formation cannot
be dissociated morphologically but must be orchestrated
by several regulators acting on distinct aspects. Indeed, in
our culture explants, blocking SDF-1 signaling did not
prevent epithelial cells in the mass to acquire apical char-
acteristics such as assembly of tight junction complexes
and primary cilia (Additional file 4 and data not shown).
Nevertheless, this polarization program could not go to
completion, as the cells remained clustered and most of
them did not acquire a basal domain.
During the remodeling of the pancreatic globular mass,
the epithelium is in contact with the mesenchyme. The
latter tissue has been proposed to provide signals that
control epithelial proliferation, differentiation and mor-
phogenesis. We have identified here SDF-1/CXCR4 signal-
ing as a potential regulator of branching morphogenesis.
Indeed, SDF-1 and its receptor, CXCR4, are expressed in
embryonic pancreas in a complementary fashion. When
epithelial cells are still organized as a non polarized mass,
SDF-1 is expressed in the mesenchyme whereas CXCR4 is
localized in the epithelium. Moreover, when SDF-1 sign-
aling is inhibited by pharmacological means or by CXCR4
genetic deficiency, pancreas morphogenesis is perturbed.
These data are consistent with a model in which the mes-
enchymally-produced SDF-1 promotes epithelial remode-
ling and thus primitive duct morphogenesis. While this
work was under review, Ueland and collaborators demon-
strated that SDF-1 controls epithelial kidney morphogen-
esis in vitro [47]. Our data in the pancreas and SMG,
together with those of Ueland et al. demonstrate the role
of SDF-1 in epithelial branching morphogenesis. The
molecular nature of the branching defects does not
involve a change in the proliferation or apoptosis indexes
(this study), but may be explained by a change in the
migration potential of epithelial cells [47].
There is no perfect overlap between the results obtained
with the pharmacological inhibition and with genetic
inactivation of SDF-1 signaling in the pancreas. Pharma-
cological inhibition of SDF-1 signaling in vitro severely
repressed branching morphogenesis, but genetic defi-
ciency in Sdf1-/- pancreas showed more modest effects in
vivo. Also, the effect of cxcr4 gene ablation only led to
abnormal pancreas morphogenesis when the organ was
cultured in vitro. We suggest that compensatory pathways
may be active in vivo but not in vitro. In our culture system,
endothelial cells are present and organized around the
epithelium like in vivo, the main difference being that
there is no blood circulation in the endothelial network in
vitro. We suggest that signal(s) coming directly or indi-
rectly from the circulation could participate in the control
of epithelial branching morphogenesis of the pancreas
and SMG. Such a model would further extend the role of
the vasculature in pancreas development, since others pre-
viously showed that blood flow through the aorta is
required for dorsal pancreas budding from the endoderm
[48,49].
In developing SMG, CXCR4 is expressed in the epithelium
and SDF-1 in the mesenchyme, like in the pancreas. This
suggests that SDF-1 controls branching morphogenesis by
a direct mechanism on the epithelium. Importantly,
CXCR7 is detected in endothelial cells of the SMG, but not
in the pancreas. In SMG explants, we observed a branch-
ing defect when SDF-1 binding to CXCR7 was inhibited
by CCX733. This suggests that SDF-1 can also indirectly
control epithelial branching morphogenesis, via the
endothelium. Activation of CXCR7 in the endothelium
may induce the production of an unidentified factor
which in turn would signal to the epithelium and act in
parallel to or amplify the direct SDF-1 effects on epithelial
morphogenesis. In the SMG we also noticed a difference
between the effects of pharmacological inhibition of SDF-
1 and genetic deficiencies induced by inactivation of the
sdf1 or cxcr4 genes. In vitro and in vivo development of cul-
tured cxcr4-/- and sdf1-/- SMG was normal, unlike develop-
ment of AMD3100- or CCX733-treated explants. This
suggests the existence of other ligands that could bind
CXCR7, or alternative signaling pathways with which
SDF-1/CXCR4/7 might interact in this organ. It has been
reported that migrating muscle progenitors cells reach theBMC Developmental Biology 2009, 9:66 http://www.biomedcentral.com/1471-213X/9/66
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anlage of the tongue in cxcr4-/- or gab1-/-, but not in the
double-mutant mice. A crosstalk between G-protein-cou-
pled receptors and tyrosine kinase receptors may contrib-
ute to compensatory mechanisms [50].
Finally, when SDF-1 signaling was blocked, the size of the
epithelium was reduced in the SMG but not in the pan-
creas. Although SDF-1 is important for survival of insulin-
producing β-cells [35], we did not observe any effect of
SDF-1 signaling on cell survival early in pancreas develop-
ment, even when e12.5 explants were cultured in the
absence of serum (data not shown). This indicates that the
survival signals are different in the two organs. A role for
SDF-1 in cell survival has already been described in several
systems [35,51]. We excluded the possibility that the role
of SDF-1 in cell survival in SMG coincided with its role in
branching morphogenesis, thereby indicating that SDF-1
plays distinct roles in the SMG.
Conclusions
In conclusion, the present work shows that the formation
of primitive ducts in the pancreas depends on remodeling
of a globular mass of epithelial cells, as described earlier
in SMG. Our data also identify SDF-1 as a factor that may
promote the transition from a mass of epithelial cells
towards monolayers in the pancreas and SMG. Under-
standing the mechanisms of such epithelial transition is
relevant to carcinogenesis, which is associated with loss of
epithelial polarity and formation of a mass of cells that
fills the ductal lumen.
Methods
Animals
C57BL/6J cxcr4 +/- mice were obtained from, and geno-
typed according to The Jackson Laboratory (Bar Harbor,
MA). The generation of SDF-1-/- mice has been described
[28]. All other mice were of the CD1 strain. The animals
were raised and treated according to the principles of lab-
oratory animal care of the University Animal Welfare
Committee.
Dissection and culture of explants
Pancreatic and SMG explants were microdissected from
mouse embryos at e12.5 and e13.5 respectively and cul-
tured on microporous membranes [40]. M199 medium
was supplemented with 10% fetal calf serum for the pan-
creas and Universal complement Insulin/Transferrin/
Selenite (BD Biosciences) for SMG culture. The medium
of pancreatic cultures was changed every day. Recom-
binant mouse SDF-1a (R&D systems, Lille, France) was
dissolved in PBS containing 0.15% bovine serum albu-
min (BSA) to 14 mg/ml (stock solution) and was added at
the final concentration of 300 ng/ml. AMD3100 (Sigma,
Bornem, Belgium) was dissolved in water to 10 mM
(stock solution) and was added at 20 μM in the culture
medium. CCX733, in DMSO, was used at 20 μM [27]. The
general caspase inhibitor VI (Calbiochem/VWR, Leuven,
Belgium) was dissolved in DMSO to 16.5 mM (stock solu-
tion) and was added at the final concentration of 25 μM.
Control explants were exposed to the same concentration
of vehicle as the test samples.
In situ hybridization
Mouse embryos were fixed overnight at 4°C in 60% etha-
nol, 30% formaldehyde and 10% acetic acid before paraf-
fin embedding. Full-length cDNAs of SDF-1 and of
CXCR4 were generated via RT-PCR using as template
reverse transcribed total RNA derived from mouse embryo
heads. DIG-labeled antisense RNA probes were produced
by in vitro transcription of the SDF-1 and CXCR4 cDNAs,
and hybridizations were performed on 16 μm-thick sec-
tions as described [52].
Immunodetection
For whole mount immunolocalization, pancreata dis-
sected from embryos were fixed in 4% paraformaldehyde
in PBS for 2 h at 4°C and treated as described [53]. For
immunofluorescence on sections, embryos or explants
were fixed, embedded and processed as described [54].
Antibodies and dilutions used in this study are given in
Additional file 6. Sections were stained with bis-benzim-
ide (Sigma, Bornem, Belgium) or with TOPRO in PBS dur-
ing incubation with the secondary antibodies.
Fluorescence was observed with a Zeiss Axiovert 200
inverted fluorescence microscope or with a Biorad confo-
cal microscope or with a Zeiss LSM510 multiphoton con-
focal microscope.
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